Group Urges Thai FDA Adopt EU-Type Drug, Food Warning System
This article was originally published in PharmAsia News
A consumer group wants Thailand's FDA to establish an early-warning system to advise the public when a dangerous drug or other product is found. The Foundation for Consumer said the European Union has such a system and Thailand should have one with the increasing number of products from China found to contain melamine. The group's head said the EU's Rapid Alert System for NonFood Products provides online information about dangerous products and lists safe alternatives as well as explaining what is being done about them. The Thai FDA's food safety expert said the agency was monitoring dangerous products and its inspectors are collecting products at random from store shelves for inspection. (Click here for more
You may also be interested in...
UK start-up Iceni Diagnostics has secured funding to develop its test for the live, intact SARS-CoV-2 virus and the UK government is evaluating a lateral flow device based on the technology for testing saliva samples as part of efforts to step up rapid testing in the country. See what Iceni’s CEO Rob Field said about it here.
The run-away US FDA advisory committee review of Biogen’s Alzheimer’s candidate was highly unusual. But like most things at the agency, not entirely unprecedented.
Trump Administration’s attempt to eliminate rebates in the US Medicare outpatient drug benefit program is the easiest and most certain item among the 11th hour pricing policy changes for the incoming Biden Administration to undo. But it still had a major impact on the dynamics of the drug pricing debate.